NEW YORK, Aug. 28 – Physiome Sciences has licensed its PathwayPrism modeling technology to 3rd Millennium to help it develop products for Huntington’s disease, the companies said on Tuesday.

The deal will allow Cambridge, Mass.-based 3rd Millennium and its academic partners “to visualize and stimulate pathways” involved in the disease, the companies said in a statement.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.

A new study of a β-thalassemia gene therapy appears promising, according to NPR.

In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.

Futurism writes that gene doping could be the next generation of cheating in sports.